Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Fate therapeutics, inc. crawled time : 23:00 save search
Fate Therapeutics Announces Termination of Collaboration Agreement with Janssen, Pipeline Prioritization, Next-Generation Programs, and Key 2023 Initiatives
Published: 2023-01-05 (Crawled : 23:00) - globenewswire.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -60.18%
H: 3.88%
C: -3.2%
collaboration therapeutics agreement
Fate Therapeutics to Host Virtual Event at the 2021 ASH Annual Meeting
Published: 2021-12-08 (Crawled : 23:00) - globenewswire.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -0.88%
H: 0.05%
C: -4.0%
therapeutics
Fate Therapeutics Announces Positive Interim Clinical Data from its FT596 and FT516 Off-the-shelf, iPSC-derived NK Cell Programs for B-cell Lymphoma
Published: 2021-08-19 (Crawled : 23:00) - globenewswire.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -15.2%
H: 0.54%
C: -7.71%
positive t-cell
513DR, Senior Manager / Manager, Genomics Core
Published: 2021-04-28 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 1.64%
H: 0.35%
C: -8.26%
genomic
507PFT, Associate Scientist / Senior Research Associate, Molecular Engineering (Genome Editing and Next Generation Sequencing)
Published: 2021-04-23 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
| Email alert
Add to watchlist
genome editing molecular research
508BG, Senior Scientist / Scientist, Cancer Immunotherapy (Solid Tumor)
Published: 2021-04-23 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
| Email alert
Add to watchlist
immunotherapy therapy cancer solid tumors
509HY, Director / Associate Director, Biostatistics
Published: 2021-04-23 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
| Email alert
Add to watchlist
510BY, Associate Scientist / Senior Research Associate, Cancer Immunotherapy
Published: 2021-04-23 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
| Email alert
Add to watchlist
immunotherapy therapy cancer research
506BS, Quality Control Associate II
Published: 2021-04-22 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -0.26%
H: 5.2%
C: 1.58%
503TG, Senior Research Associate, MSAT
Published: 2021-04-19 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -0.36%
H: 3.45%
C: -1.49%
research
504TG, Associate Scientist, MSAT
Published: 2021-04-19 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -0.36%
H: 3.45%
C: -1.49%
505YQ, Associate Scientist / Senior Research Associate, Process Development Engineering
Published: 2021-04-19 (Crawled : 23:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -0.36%
H: 3.45%
C: -1.49%
research
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.